Skip to main content

Enhancement of Antitumor Resistance by Mycobacterial Products and Endotoxin

  • Chapter

Abstract

It has been more than 100 years since the suggestion was made that the control of cancer was mediated by immunologic methods. This hypothesis was based on the observation that tumors either partially or totally regressed in a few patients following an acute bacterial infection. In 1911, William Coley pioneered the study of mixed bacterial vaccines or their product known as “Coley’s toxin,” for treating cancers, and there is no doubt that these vaccines had some effect in many cases (Nauts et al., 1946). The effective ingredient appeared to be endotoxin, which caused hemorrhagic necrosis of the tumors. Thus, Gratia and Linz discovered in guinea pigs (1931) and Shwartzman and Michailovsky in mice (1932) that when animals with solid tumors are given single i.v. or i.p. inoculations with small doses of endotoxin, their tumors became hemorrhagic within 24 hr. This was originally done by analogy with the local Shwartzman reaction, with the idea that some hypothetical tumor virus might have prepared the site. It appeared that this type of tumor damage was mediated indirectly because little of the injected endotoxin would be likely to make contact with tumor cells, and would not exert any direct cytotoxicity in any case (Shapiro, 1940; Brailovsky et al., 1973).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adam, A., Cirobaru, R., Ellouz, F., Petit, J.-F., and Lederer, E., 1974, Adjuvant activity of monomeric bacterial cell wall peptidoglycans, Biochem. Biophys. Res. Commun. 56:561.

    Article  PubMed  CAS  Google Scholar 

  • Alexander, P., 1977, Back to the drawing board—The need for more realistic model systems for immunotherapy, Cancer 40:467.

    Article  PubMed  CAS  Google Scholar 

  • Alexander, P., and Evans, R., 1971, Endotoxin and double-stranded RNA render macrophages cytotoxic, Nature New Biol. 232:76.

    PubMed  CAS  Google Scholar 

  • Amano, K., Ribi, E., and Cantrell, J. L., 1982, Different structural requirements of endotoxic glycolipid for tumor regression and endotoxic activity, Biochem. Biophys. Res. Comm. 106:667.

    Article  Google Scholar 

  • Anacker, R. L., Barclay, W. R., Brehmer, W., Larson, C. L., and Ribi, E., 1967, Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG, J. Immunol. 98:1265.

    PubMed  CAS  Google Scholar 

  • Azuma, I., Ribi, E., Meyer, T. J., and Zbar, B., 1974, Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and P3, J. Natl. Cancer Inst. 52:95.

    PubMed  CAS  Google Scholar 

  • Barclay, W. R., Anacker, R. L., Brehmer, W., and Ribi, E., 1967, Effects of oil-treated mycobacterial cell walls on the organs of mice, J. Bacteriol 94:1736.

    PubMed  CAS  Google Scholar 

  • Berendt, M. J., North, R. J., and Kirsten, D. P., 1978, The immunological basis of endo-toxin-induced tumor regression: Requirement for T-cell-mediated immunity, J. Exp. Med. 148:1550.

    Article  PubMed  CAS  Google Scholar 

  • Brailovsky, C., Trudel, M., Lallier, R., and Nigam, V. N., 1973, Growth of normal and transformed rat embryo fibroblasts: Effects of glycolipids from Salmonella minnesota R mutants, J. Cell Biol. 57:124.

    Article  PubMed  CAS  Google Scholar 

  • Braun, V., Rehn, K., and Wolff, H., 1970, Supramolecular structure of the rigid layer of the cell wall of Salmonella, Serratia, Proteus, and Pseudomonas fluorescens: Number of lipoprotein molecules in a membrane layer, Biochemistry 9:5041.

    Article  PubMed  CAS  Google Scholar 

  • Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B., 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. USA 72:3666.

    Article  PubMed  CAS  Google Scholar 

  • Chapman, H. A., Jr., and Hibbs, J. B., Jr., 1977, Modulation of macrophage tumoricidal capability by components of normal serum: A central role for lipid, Science 197:282.

    Article  PubMed  CAS  Google Scholar 

  • Ellouz, F., Adam, A., Ciorbaru, R., and Lederer, E., 1974, Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives, Biochem. Biophys. Res. Commun. 59:1317.

    Article  PubMed  CAS  Google Scholar 

  • Galanos, C., Lüderitz, O., and Westphal, O., 1969, A new method for the extraction of R lipopolysaccharides, Eur. J., Biochem. 9:245.

    Article  CAS  Google Scholar 

  • Granger, D. L., Yamamato, K., and Ribi, E., 1976, Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets,J. Immunol. 116:482.

    PubMed  CAS  Google Scholar 

  • Gratia, A., and Linz, R., 1931, Le phénomène de Shwartzman dans la sarcome du cobaye, C. R. Soc. Biol. 108:427.

    Google Scholar 

  • Haskins, W. T., Landry, M., Milner, K. C., and Ribi, E., 1961, Biological properties of parent endotoxins and lipoid fractions, with a kinetic study of acid-hydrolyzed endotoxin, JExp. Med. 114:665.

    Article  CAS  Google Scholar 

  • Hausman, M. S., Snyderman, R., and Mergenhagen, S. E., 1972, Humoral mediators of Chemotaxis of mononuclear leukocytes, JInfect. Dis. 125:595.

    Article  CAS  Google Scholar 

  • Hibbs, J. B., Jr., Taintor, R. R., Chapman, H. A., Jr., and Weinberg, J. B., 1977, Macrophage tumor killing: Influence of the local environment, Science 197:279.

    Article  PubMed  Google Scholar 

  • Hoffmann, M. K., Green, S., Old, L. J., and Oettgen, H. F., 1976, Serum containing en-dotoxin-induced tumour necrosis factor substitutes for helper T cells, Nature (London) 263:416.

    Article  CAS  Google Scholar 

  • Johnson, A. G., and Nowotny, A., 1964, Relationship of structure to function in bacterial O antigens. III. Biological properties of endotoxins, JBacteriol. 87:809.

    CAS  Google Scholar 

  • Joiner, K. A., and Wolff, S. M., 1981, The role of endotoxin in human disease and its therapy, in: Augmenting Agents in Cancer Therapy (Hersh, E. M, Chirigos, M. A., and M. J. Mastrangclo, eds.), pp. 125–134, Raven Press, New York.

    Google Scholar 

  • Kelly, M. T., McLaughlin, C. A., and Ribi, E., 1978, Eradication of microscopic lymph node metastases of the guinea pig line 10 tumor after intralesional injection of endotoxin plus mycobacterial components, Cancer Immunol. Immunother. 4:29.

    Article  Google Scholar 

  • Kleinschuster, S. J., Rapp, H. J., Leukcr, D. C., and Kainer, R. A., 1977, Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine, J. Satl. Cancer Inst. 58:1807.

    CAS  Google Scholar 

  • Kotani, S., Watanabe, Y., Kinoshita, F., Shimono, T., Morisaki, T., Shiba, T., Kusumoto, S., Tarumi, Y., and Ikenaka, K., 1975, Immunoadjuvant activities of synthetic S-acetylmuramylpeptides or amino acids, Biken J. 18:105.

    PubMed  CAS  Google Scholar 

  • Lüderitz, O., Galanos, C., Lehmann, V., Norminen, M., Rietschel, E. T., Rosenfelder, G., Simon, M., and Westphal, O., 1973, Lipid A: Chemical structure and biological activity, JInfect. Dis. 128(Suppl.):17.

    Article  Google Scholar 

  • Lüderitz, O., Galanos, C., Lehmann, V., Mayer, H., Rietschel, E. T., and Weckesser, J., 1978, Chemical structure and biological activities of lipid A’s from various bacterial families, Saturwissenschaften 65:578.

    Article  Google Scholar 

  • Mclntire, F. C., Hargie, M. P., Schenck, J. R., Finley, R. A., Sievert, H. W., Rietschel, E. T., and Rosenstreich, D. L., 1976, Biologic properties of nontoxic derivatives of lipo-polysaccharide from Escherichia coli K235, J. Immunol. 117:674.

    Google Scholar 

  • McLaughlin, C. A., Bickel, W. D., Kyle, J. S., and Ribi, E., 1978, Synergistic tumor-regressive activity observed following treatment of line-10 heptocellular carcinomas with deproteinized BCG cell walls and mutant Salmonella typhimunum glycolipid, Cancer Immunol. Immunother. 5:45.

    Article  Google Scholar 

  • Merser, C., Sinay, P., and Adam, A., 1975, Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives, Bwchem. Biophys. Res. Commun. 66:1316.

    Article  CAS  Google Scholar 

  • Meyer, R. J., Ribi, E., Azuma, I., and Zbar, B., 1974, Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma, J. Natl. Cancer Inst. 52:103.

    PubMed  CAS  Google Scholar 

  • Milner, K. C., and Finkelstein, R. A., 1966, Bioassay of endotoxin: Correlation between pyrogenicity for rabbits and lethality for chick embryos, JInfect. Dis. 116:529.

    Article  CAS  Google Scholar 

  • Milner, K. C., Rudbach, J. A., and Ribi, E., 1971, Bacterial endotoxins: General characteristics, in: Microbial Toxins: A Comprehensive Treatise (G. Weinbaum, S. Kadis, and S. J. Ajl, eds.), pp. 1–65, Academic Press, New York.

    Google Scholar 

  • Nakae, T., 1976, Identification of the outer membrane proteins of E. coli that produce transmembrane channels in reconstituted vesicle membranes, Biochem. Biophys. Res. Commun. 71:877.

    Article  PubMed  CAS  Google Scholar 

  • Nauts, H. C., Swift, W. E., and Coley, B. L., 1946, The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M. D., reviewed in the light of modern research, Cancer Res. 6:205.

    PubMed  CAS  Google Scholar 

  • Nowotny, A., 1963a, Endotoxoid preparations, Nature (London) 197:721.

    Article  CAS  Google Scholar 

  • Nowotny, A., 1963b, Relation of structure to function in bacterial O-antigens. II. Fractionation of lipids present in Boivin-type endotoxin of Serratia marcescens, J. Bactenol. 85:427.

    CAS  Google Scholar 

  • Okuyama, H., Onoc, K., Takeda, J., and Morikawa, K., 1976, Histological studies on the adjuvanticity of BCG-cell wall, Recent Adv. RES Res. 16:67.

    Google Scholar 

  • Perrault, A., and Shear, M. J., 1949, Ehe bacterial cell of 5. marcescens as a source of tu-mor-necrotising polysaccharide, Cancer Res. 9:626.

    Google Scholar 

  • Rapp, H. J., 1973, A guinea pig model for tumor immunology: A summary, Isr. J. Med. Sci. 9:366.

    PubMed  CAS  Google Scholar 

  • Ribi, E., Milner, K. C., and Perrine, T. D., 1959, Endotoxic and antigenic fractions from the cell wall of Salmonella ententidis: Methods for separation and some biologic activities, J. Immunol. 82:75.

    PubMed  CAS  Google Scholar 

  • Ribi, E., Haskins, W. T., Eandy, M., and Milner, K. C., 1961, Preparation and host-reactive properties of endotoxin with low content of nitrogen and lipid, JExp. Med. 114: 647.

    Article  CAS  Google Scholar 

  • Ribi, E., Anacker, R. L., Brown, R., Haskins, W. T., Malmgren, B., Milner, K. C., and Rudbach, J. A., 1966a, Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate, J. Bactenol. 92:1493.

    CAS  Google Scholar 

  • Ribi, E., Larson, C., Wicht, W., List, R., and Goode, G., 1966b, Effective nonliving vaccine against experimental tuberculosis in mice, J. Bactenol. 91:975.

    CAS  Google Scholar 

  • Ribi, E., Anacker, R. L., Barclay, W. R., Brehmer, W., Harris, S. C., Leif, W. R., and Simmons, J., 1971, Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey, JInfect. Dis. 123:527.

    Article  CAS  Google Scholar 

  • Ribi, E., Parker, R., and Milner, K. C., 1974, Microparticulate gel chromatography accelerated by centrifugal force and pressure, Methods Biochem. Anal. 22:355.

    Article  PubMed  CAS  Google Scholar 

  • Ribi, E., Granger, D. L., Milner, K. C., and Strain, S. M., 1975, Brief communication: Tumor regression caused by endotoxins and mycobacterial fractions, J. Natl. Cancer Inst. 55:1253.

    PubMed  CAS  Google Scholar 

  • Ribi, E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., and Strain, S. M., 1976a, Immunotherapy with nonviable microbial components, Ann. NY. Acad. Sci. 277:228.

    Article  PubMed  CAS  Google Scholar 

  • Ribi, E., Milner, K. C., Kelly, M. T., Granger, D. L., Yamamoto, K., McLaughlin, C. A., Brehmer, W., Strain, S. M., Smith, R. F., and Parker, R., 1976b, Structural requirements of microbial agents for immunotherapy of the guinea pig line-10 tumor, in: BCC in Cancer Immunotherapy (G. Lamoureux, R. Turcotte, and V. Portelance, eds.), pp. 51–61, Grüne Sc Stratton, New York.

    Google Scholar 

  • Ribi, E., McLaughlin, G. A., Gantrell, J. L., Brehmer, W., Azuma, I., Yamamura, Y., Strain, S. M., Hwang, K. M., and Toubiana, R., 1978, Immunotherapy for tumors with microbial constituents or their synthetic analogues: A review, in: Immunotherapy of Human Cancer, pp. 131–154, Raven Press, New York.

    Google Scholar 

  • Ribi, E., Parker, R., Strain, S. M., Mizuno, Y., Nowotny, A., Von Eschen, K. B., Cantrell, J. L., McLaughlin, G. A., Hwang, K. M., and Goren, M. B., 1979a, Peptides as requirement for immunotherapy of the guinea pig line-10 tumor with endotoxins, Cancer Immunol. Immunother. 7:43.

    Article  Google Scholar 

  • Ribi, E., Gantrell, J. L., Von Eschen, K., and Schwartzman, S., 1979b, Enhancement of endotoxic shock by adjuvant dipeptide (MDP), Cancer Res. 39:4756.

    PubMed  CAS  Google Scholar 

  • Ribi, E., Gantrell, J. L., Schwartzman, S. M., and Parker, R., 1981, BCG cell wall skeleton, P3, MDP and other microbial components — Structure activity studies in animals models, in: Augmenting Agents in Cancer Therapy (E. M. Hersh, M. A. Chirigos, and M.J. Mastrangelo, eds.), pp. 15–31, Raven Press, New York.

    Google Scholar 

  • Ribi, E., Amano, K., Gantrell, J., Schwartzman, S., Parker, R., and Takayama, K., 1982, Preparation and anti-tumor activity of nontoxic lipid A, Cancer Immunol. Immunother. 12:91.

    Article  CAS  Google Scholar 

  • Richman, S. P., Gutterman, J. U., Hersh, E. M., and Ribi, E., 1978, Phase I-II study of intratumor immunotherapy with BCG cell wall skeleton plus P3, Cancer Immunol. Immunother. 5:41.

    Article  Google Scholar 

  • Rosner, M. R., Tang, J. Y., Barzilay, I., and Khorana, H. G., 1979, Structure of the lipo-polysaccharide from Escherichia coli heptoseless mutant, J. Biol. Chem. 254:5906.

    PubMed  CAS  Google Scholar 

  • Schenck, J. R., Hargie, M. P., Brown, M. S., Ebert, D. S., Yoo, A. L., and Mclntire, F. C., 1969, The enhancement of antibody formation by Escherichia coli lipopolysaccharide and detoxified derivatives, J. Immunol. 102:1411.

    PubMed  CAS  Google Scholar 

  • Shapiro, C. J., 1940, The effect of a toxic carbohydrate complex from S. enteritidis on transplantable rat tumors in tissue culture, Am. J. Hyg. 31(Sect. B):114.

    Google Scholar 

  • Shwartzman, G., and Michailovsky, N., 1932, Phenomenon of local skin reactivity to bacterial filtrates in the treatment of mouse sarcoma 180, Proc. Soc. Exp. Biol, Med. 29: 737.

    Google Scholar 

  • Takayama, K., Ribi, E., and Cantrell, J. L., 1981, Isolation of a nontoxic lipid A fraction containing tumor regression activity, Cancer Res. 41:2654.

    PubMed  CAS  Google Scholar 

  • Vosika, G. J., Schmidtke, J. R., Goldman, A., Ribi, E., Parker, R., and Gray, G. R., 1979a, Intralesional immunotherapy of malignant melanoma with Mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate, Cancer 44:495.

    Article  PubMed  CAS  Google Scholar 

  • Vosika, G. J., Schmidtke, J. R., Goldman, A., Parker, R., Ribi, E., and Gray, G. R., 1979b, Phase I–II study of intralesional immunotherapy with oil attached Mycobacterium smegmatis cell wall skeleton and trehalose dimycolate, Cancer Immunol. Immunother. 6:135.

    Article  Google Scholar 

  • Westphal, O., and Lüderitz, O., 1954, Chemische Erforschung von Lipopolysacchariden gram negativer Bakterien, Angew. Chem. 66:407.

    Article  CAS  Google Scholar 

  • Zbar, B., Bernstein, I. D., and Rapp, H. J., 1971, Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin, J. Natl. Cancer Inst. 46:831.

    PubMed  CAS  Google Scholar 

  • Zbar, B., Ribi, E., and Rapp, H. J., 1973, An experimental model for immunotherapy of cancer, Natl. Cancer Inst. Monogr. 39:3.

    PubMed  CAS  Google Scholar 

  • Zbar, B., Ribi, E., Kelly, M., Granger, D., Evans, C., and Rapp, H. J., 1976, Immunologic approaches to the treatment of human cancer based on a guinea pig model, Cancer Immunol. Immunother. 1:127.

    Article  Google Scholar 

  • Zbar, B., Canti, G., Ashley, M. P., Rapp, H. J., Hunter, J. T., and Ribi, E., 1979, Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery, Cancer Res. 39:1597.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this chapter

Cite this chapter

Ribi, E., Cantrell, J.L., Takayama, K., Amano, Ki. (1983). Enhancement of Antitumor Resistance by Mycobacterial Products and Endotoxin. In: Nowotny, A. (eds) Beneficial Effects of Endotoxins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4364-6_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4364-6_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4366-0

  • Online ISBN: 978-1-4684-4364-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics